Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication
N-[(1R)-2-[4-(1-Methylpiperidin-4-yl)piperazin-1-yl]-2-oxo-1-phenylethyl]-1H-indole-6-carboxamide
Approved for COVID-19 treatment (China, India, Russia) Experimental Antiviral Sep/18/2020
N-({(2S)-1-[(3R)-3-Amino-4-(2-fluorophenyl)butanoyl]pyrrolidin-2-YL}methyl)benzamide
Potential treatment - theoretical effect Experimental Antiviral Sep/18/2020
6-Carbamimidoyl-4-(3-hydroxy-2-methyl-benzoylamino)-naphthalene-2-carboxylic acid methyl ester
Potential treatment - theoretical effect Experimental Antiviral Sep/18/2020
Fimepinostat
Potential treatment - theoretical effect Experimental Antiviral Sep/18/2020
4SC-202
Potential treatment - theoretical effect Experimental Antiviral Sep/18/2020
Darexaban
Potential treatment - theoretical effect Experimental Antiviral Sep/18/2020
Capsazepine
Potential treatment - theoretical effect Experimental Antiviral Sep/18/2020
RTAM-PAP1
Potential treatment - theoretical effect Experimental Antiviral Sep/17/2020
[2-[[(3R)-1,1-Dioxothiolan-3-yl]-(2-methylpropyl)amino]-2-oxoethyl] 3-(furan-2-carbonylamino)-4-methylbenzoate
Potential treatment - theoretical effect Experimental Antiviral Sep/17/2020
[2-[[(2R)-Butan-2-yl]-[(3R)-1,1-dioxothiolan-3-yl]amino]-2-oxoethyl] 3-(furan-2-carbonylamino)-4-methylbenzoate
Potential treatment - theoretical effect Experimental Antiviral Sep/17/2020
(5S,5Ar,8aR,9S)-5-[[(2S,4aR,6R,7S,8R,8aS)-7,8-dihydroxy-2-methyl-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxin-6-yl]oxy]-9-(4-hydroxy-3,5-dimethoxyphenyl)-5a,6,8a,[2]benzofuro[6,5-f][1,3]benzodioxol-8-one
Potential treatment - theoretical effect Experimental Antiviral Sep/17/2020
[(2S,3S,4S,5S)-5-Hydroxy-3,4-bis(pyridine-3-carbonyloxy)-5-(pyridine-3-carbonyloxymethyl)oxolan-2-yl]methyl pyridine-3-carboxylate
Potential treatment - theoretical effect Experimental Antiviral Sep/17/2020
RX-3117
Potential treatment - theoretical effect Experimental Antiviral Sep/16/2020
2-[(1R)-1-Naphth-1-ylethyl]-2,3-dihydro-1H-isoindol hydrochloride
Potential treatment - pre-clinical evidence Experimental Antiviral Sep/15/2020
7-Bromo-3-[(7-bromo-4-hydroxy-2-oxo-1H-quinolin-3-yl)methyl]-4-hydroxy-1H-quinolin-2-one
Potential treatment - theoretical effect Experimental Antiviral Sep/14/2020
BD-368-2
Potential treatment - pre-clinical evidence Experimental Antiviral Sep/14/2020
Z93
Potential treatment - theoretical effect Experimental Antiviral Sep/13/2020
Canrenone
Potential treatment - clinical evidence Experimental Other treatment Sep/11/2020
sdAb 1E2
Potential treatment - pre-clinical evidence Experimental Antiviral Sep/10/2020
sdAb 5F8
Potential treatment - pre-clinical evidence Experimental Antiviral Sep/10/2020